Relmada Therapeutics, Inc.: Form S-1/A, filed Oct 11, 2019
Filed with the SEC on Oct 11, 2019 and accepted by EDGAR at Oct 11, 2019, 16:23 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-19-020211. Last ingested by Listed: Nov 13, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.